Lykke Hinsch Gylvin

Statistics

Publications

Citations

215

H-Index

Active since

2014

Affiliations

Roche (Switzerland)(Current)

NIHR Leeds Musculoskeletal Biomedical Research Unit

Lykke Hinsch Gylvin is an author at Roche (Switzerland) specializing in pharmacotherapy, rheumatoid arthritis pharmacotherapy, and rituximab-based therapy.

Publications per year

2014–2014

Publications

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Paul Emery, J.E. Gottenberg, Andrea Rubbert‐Roth et al. · Annals of the Rheumatic Diseases · 2014 · 156 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Charles Peterfy, Paul Emery, Paul P. Tak et al. · Annals of the Rheumatic Diseases · 2014 · 59 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

1–2 of 2